Knights Of Columbus Asset Advisors LLC Reata Pharmaceuticals Inc Transaction History

Knights Of Columbus Asset Advisors LLC

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$78.27 - $151.29 $1.05 Million - $2.03 Million
-13,433 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$94.25 - $132.81 $40,433 - $56,975
429 Added 3.3%
13,433 $1.34 Million
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $1.33 Million - $2.4 Million
13,004 New
13,004 $1.61 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email